FTC Says Supplement Maker to Pay $5.5M on False Advertising Charges
The Federal Trade Commission is requiring a Health Sciences U.S.A. and two affiliated Canadian companies to pay $5.5 million to settle charges that it falsely advertised that its dietary supplements could help consumers lose weight and treat or prevent colds…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
and other illnesses. The $5.5 million will be used for refunds to consumers who purchased Accelis, nanoSLIM, and any Cold MD, Germ MD, and Allergy MD product. These supplements were sold over the Internet and were widely available at retail stores. In addition, the settlement requires the marketer to stop making deceptive health claims about the products.